173 related articles for article (PubMed ID: 8947869)
21. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK;
Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337
[TBL] [Abstract][Full Text] [Related]
22. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats.
Taylor SS; Goodfellow MR; Browne WJ; Walding B; Murphy S; Tzannes S; Gerou-Ferriani M; Schwartz A; Dobson JM
J Small Anim Pract; 2009 Nov; 50(11):584-92. PubMed ID: 19891724
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
24. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981).
Mooney SC; Hayes AA; MacEwen EG; Matus RE; Geary A; Shurgot BA
J Am Vet Med Assoc; 1989 Mar; 194(5):696-702. PubMed ID: 2925488
[TBL] [Abstract][Full Text] [Related]
25. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
26. Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen.
Krupa A; de Vos J; Van Eetvelde L; Teske E
J Feline Med Surg; 2022 Aug; 24(8):e203-e213. PubMed ID: 35748790
[TBL] [Abstract][Full Text] [Related]
27. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
28. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
[TBL] [Abstract][Full Text] [Related]
29. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.
Krick EL; Cohen RB; Gregor TP; Salah PC; Sorenmo KU
J Vet Intern Med; 2013; 27(1):134-40. PubMed ID: 23157371
[TBL] [Abstract][Full Text] [Related]
30. Combined Hypofractionated Radiotherapy and Chemotherapy Versus Hypofractionated Radiotherapy Alone for Cats with Localized Sinonasal Lymphoma.
Goto S; Iwasaki R; Sakai H; Mori T
J Am Anim Hosp Assoc; 2022 Sep; 58(5):254-261. PubMed ID: 36049238
[TBL] [Abstract][Full Text] [Related]
31. Alimentary lymphoma in cats: 28 cases (1988-1993).
Mahony OM; Moore AS; Cotter SM; Engler SJ; Brown D; Penninck DG
J Am Vet Med Assoc; 1995 Dec; 207(12):1593-8. PubMed ID: 7493898
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
[TBL] [Abstract][Full Text] [Related]
33. Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: a retrospective study of 23 cases.
Oberthaler KT; Mauldin E; McManus PM; Shofer FS; Sorenmo KU
J Feline Med Surg; 2009 Apr; 11(4):259-65. PubMed ID: 18974017
[TBL] [Abstract][Full Text] [Related]
34. Therapy for Australian cats with lymphosarcoma.
Malik R; Gabor LJ; Foster SF; McCorkell BE; Canfield PJ
Aust Vet J; 2001 Dec; 79(12):808-17. PubMed ID: 11837901
[TBL] [Abstract][Full Text] [Related]
35. Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997).
Kristal O; Lana SE; Ogilvie GK; Rand WM; Cotter SM; Moore AS
J Vet Intern Med; 2001; 15(2):125-30. PubMed ID: 11300595
[TBL] [Abstract][Full Text] [Related]
36. Hypersensitivity reactions associated with L-asparaginase administration in 142 dogs and 68 cats with lymphoid malignancies: 2007-2012.
Blake MK; Carr BJ; Mauldin GE
Can Vet J; 2016 Feb; 57(2):176-82. PubMed ID: 26834270
[TBL] [Abstract][Full Text] [Related]
37. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of CHOP and COP-BLAM chemotherapy in highly malignant non-Hodgkin's lymphoma].
Gerhartz HH; Thiel E; Hiller E; Nerl C; Wilmanns W; Huhn D
Dtsch Med Wochenschr; 1986 Oct; 111(40):1511-5. PubMed ID: 2428572
[TBL] [Abstract][Full Text] [Related]
39. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
40. Treatment of older patients with mantle-cell lymphoma.
Kluin-Nelemans HC; Hoster E; Hermine O; Walewski J; Trneny M; Geisler CH; Stilgenbauer S; Thieblemont C; Vehling-Kaiser U; Doorduijn JK; Coiffier B; Forstpointner R; Tilly H; Kanz L; Feugier P; Szymczyk M; Hallek M; Kremers S; Lepeu G; Sanhes L; Zijlstra JM; Bouabdallah R; Lugtenburg PJ; Macro M; Pfreundschuh M; Procházka V; Di Raimondo F; Ribrag V; Uppenkamp M; André M; Klapper W; Hiddemann W; Unterhalt M; Dreyling MH
N Engl J Med; 2012 Aug; 367(6):520-31. PubMed ID: 22873532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
